Imugene
(ASX) IMU
Imugene Financials at a Glance
Market Cap
$49.98M
Revenue (TTM)
$1.30M
Net Income (TTM)
$187.81M
EPS (TTM)
$-0.22
P/E Ratio
-0.63
Dividend
$0.00
Beta (Volatility)
0.15 (Low)
Dividend
$0.00
Beta (Volatility)
0.15 (Low)
Price
$0.14
Volume
526,321
Open
$0.14
Price
$0.14
Volume
526,321
Open
$0.14
Previous Close
$0.14
Daily Range
$0.14 - $0.14
52-Week Range
$0.13 - $0.51
Dividend
$0.00
Beta (Volatility)
0.15 (Low)
Price
$0.14
Volume
526,321
Open
$0.14
Previous Close
$0.14
Daily Range
$0.14 - $0.14
52-Week Range
$0.13 - $0.51
IMU News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Imugene
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
Leslie Chong
Website
imugene.comHeadquarters
Sydney, NSW 2000, AU
IMU Financials
Key Financial Metrics (TTM)
Gross Margin
-66%
Operating Margin
-20%
Net Income Margin
-19%
Return on Equity
-111%
Return on Capital
-1%
Return on Assets
-86%
Earnings Yield
-1.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$49.98M
Shares Outstanding
357.03M
Volume
526.32K
Short Interest
0.00%
Avg. Volume
1.58M
Financials (TTM)
Gross Profit
$4.40M
Operating Income
$70.94M
EBITDA
$67.42M
Operating Cash Flow
$75.57M
Capital Expenditure
$14.46M
Free Cash Flow
$90.03M
Cash & ST Invst.
$21.94M
Total Debt
$10.65M
Imugene Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$5.21M
-164.5%
Gross Margin
0.00%
N/A
Market Cap
$49.98M
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
$37.82M
+45.0%
EBITDA
$40.07M
+46.3%
Quarterly Fundamentals
Net Cash
$9.11M
-93.3%
Accounts Receivable
$4.41M
-78.4%
Inventory
$1.67M
N/A
Long Term Debt
$48.25K
-98.8%
Short Term Debt
$4.98M
N/A
Return on Assets
-86.46%
N/A
Return on Invested Capital
-1.25%
N/A
Free Cash Flow
$25.97M
+56.7%
Operating Cash Flow
$25.97M
+46.4%